Star Health & Allied Insurance Company Ltd is Rated Hold

1 hour ago
share
Share Via
Star Health & Allied Insurance Company Ltd is rated 'Hold' by MarketsMojo. This rating was last updated on 20 Mar 2026, reflecting a reassessment of the stock’s prospects. However, all fundamentals, returns, and financial metrics discussed below are current as of 17 May 2026, providing investors with the latest view on the company’s position in the market.
Star Health & Allied Insurance Company Ltd is Rated Hold

Rating Context and Overview

On 20 Mar 2026, MarketsMOJO revised the rating for Star Health & Allied Insurance Company Ltd from 'Sell' to 'Hold', accompanied by a significant increase in its Mojo Score from 35 to 58. This adjustment signals a more balanced outlook on the stock, suggesting that while it may not be a strong buy, it is no longer considered a sell. The 'Hold' rating indicates that investors should maintain their current positions and monitor the stock closely, as it exhibits a mix of strengths and challenges.

Here’s How the Stock Looks Today

As of 17 May 2026, Star Health & Allied Insurance Company Ltd presents a nuanced profile across key investment parameters. The company’s current Mojo Grade is 'Hold', supported by a composite score of 58.0, reflecting moderate confidence in its medium-term prospects. The stock’s recent price movement shows a 1-day decline of 1.23%, with a 1-month gain of 4.75% and a year-to-date return of 10.25%. Over the past year, the stock has delivered a robust 18.97% return, outperforming the broader BSE500 index, which has declined by 1.67% during the same period.

Quality Assessment

The quality grade for Star Health stands at 'average'. The company demonstrates strong long-term fundamental strength, with operating profits growing at a compound annual growth rate (CAGR) of 19.38%. This indicates effective operational management and the ability to generate earnings growth over time. However, this strength is tempered by a concerning decline in net sales, which have contracted at an annual rate of -49.69%. This negative sales trend suggests challenges in top-line growth, which could impact future profitability if not addressed.

Valuation Considerations

Valuation remains a critical factor in the current rating. The stock is classified as 'very expensive', trading at a price-to-book (P/B) ratio of 3.9, which is a premium compared to its peers’ historical averages. The company’s return on equity (ROE) stands at 7.5%, a modest figure that does not fully justify the elevated valuation. Investors should be cautious, as the premium pricing implies expectations of future growth that the company must meet to sustain its current valuation levels.

Financial Trend Analysis

The financial grade is assessed as 'flat', reflecting a period of stagnation in recent results. The latest quarterly data ending March 2026 shows flat performance, with profits declining by 13.8% over the past year despite the stock’s positive price returns. This divergence between earnings and stock price suggests that market sentiment may be driven by factors beyond immediate financial results, such as sector outlook or institutional interest.

Technical Outlook

Technically, the stock is rated 'bullish'. The positive momentum is evident in its recent price gains over one and three months, indicating investor confidence in the near term. This technical strength supports the 'Hold' rating by suggesting that while the stock may not be a compelling buy at current levels, it is not showing signs of imminent decline either.

Institutional Interest and Market Position

Institutional investors hold a significant 35.36% stake in Star Health & Allied Insurance Company Ltd. This high level of institutional ownership often reflects thorough fundamental analysis and confidence from sophisticated market participants. Their involvement can provide stability and support for the stock price, especially during periods of market volatility.

Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!

  • - Complete fundamentals package
  • - Technical momentum confirmed
  • - Reasonable valuation entry

Add to Your Radar Now →

What the Hold Rating Means for Investors

The 'Hold' rating on Star Health & Allied Insurance Company Ltd suggests a cautious stance. Investors currently holding the stock are advised to maintain their positions, as the company exhibits a blend of strengths and vulnerabilities. The strong operating profit growth and bullish technical indicators provide reasons for optimism, while the expensive valuation and flat financial trend counsel prudence.

For prospective investors, the rating implies that the stock may not offer immediate upside potential at current prices but remains a viable option for those with a medium to long-term horizon who are comfortable with the risks associated with valuation and sales growth challenges.

Sector and Market Context

Operating within the insurance sector, Star Health & Allied Insurance Company Ltd is classified as a small-cap stock. Its market-beating performance over the past year, despite a challenging broader market environment, highlights its relative resilience. However, investors should consider sector-specific risks and the company’s ability to sustain growth amid competitive pressures and regulatory changes.

Summary of Key Metrics as of 17 May 2026

- Mojo Score: 58.0 (Hold grade)
- Market Cap: Small-cap
- 1-Year Stock Return: +18.97%
- Operating Profit CAGR: 19.38%
- Net Sales Growth: -49.69% annually
- ROE: 7.5%
- Price to Book Value: 3.9
- Institutional Holdings: 35.36%

These metrics collectively underpin the current rating and provide a comprehensive view of the company’s investment profile.

Conclusion

Star Health & Allied Insurance Company Ltd’s 'Hold' rating reflects a balanced assessment of its current fundamentals, valuation, financial trends, and technical outlook. While the company shows promising operational profit growth and technical strength, valuation concerns and flat recent financial results temper enthusiasm. Investors should weigh these factors carefully and consider their investment horizon and risk tolerance when making decisions regarding this stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News